RU2045518C1 - Производные индола или их фармацевтически приемлемые соли и способ их получения - Google Patents
Производные индола или их фармацевтически приемлемые соли и способ их получения Download PDFInfo
- Publication number
- RU2045518C1 RU2045518C1 SU914895529A SU4895529A RU2045518C1 RU 2045518 C1 RU2045518 C1 RU 2045518C1 SU 914895529 A SU914895529 A SU 914895529A SU 4895529 A SU4895529 A SU 4895529A RU 2045518 C1 RU2045518 C1 RU 2045518C1
- Authority
- RU
- Russia
- Prior art keywords
- multiplet
- doublet
- singlet
- triplet
- indol
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 title claims abstract description 9
- 150000002475 indoles Chemical class 0.000 title claims abstract description 7
- 229940054051 antipsychotic indole derivative Drugs 0.000 title claims abstract description 5
- 238000000034 method Methods 0.000 title abstract description 19
- 230000015572 biosynthetic process Effects 0.000 title abstract 2
- 238000003786 synthesis reaction Methods 0.000 title abstract 2
- -1 10,11-dihydro-5H-dibenzoazepinyl Chemical group 0.000 claims abstract description 44
- 150000001875 compounds Chemical class 0.000 claims abstract description 28
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 25
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 15
- 239000001257 hydrogen Substances 0.000 claims abstract description 15
- 125000001424 substituent group Chemical group 0.000 claims abstract description 14
- YJTKZCDBKVTVBY-UHFFFAOYSA-N 1,3-Diphenylbenzene Chemical group C1=CC=CC=C1C1=CC=CC(C=2C=CC=CC=2)=C1 YJTKZCDBKVTVBY-UHFFFAOYSA-N 0.000 claims abstract description 12
- 125000002947 alkylene group Chemical group 0.000 claims abstract description 12
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims abstract description 11
- 150000002431 hydrogen Chemical class 0.000 claims abstract description 10
- 229910052736 halogen Inorganic materials 0.000 claims abstract description 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims abstract description 5
- 150000002367 halogens Chemical class 0.000 claims abstract description 5
- 125000004450 alkenylene group Chemical group 0.000 claims abstract description 3
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims abstract description 3
- 125000001484 phenothiazinyl group Chemical group C1(=CC=CC=2SC3=CC=CC=C3NC12)* 0.000 claims abstract description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 3
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 8
- 125000005115 alkyl carbamoyl group Chemical group 0.000 claims description 5
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 5
- 125000006239 protecting group Chemical group 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 125000004043 oxo group Chemical group O=* 0.000 claims description 2
- 125000001644 phenoxazinyl group Chemical group C1(=CC=CC=2OC3=CC=CC=C3NC12)* 0.000 claims description 2
- 125000004448 alkyl carbonyl group Chemical group 0.000 claims 1
- 108010029908 3-oxo-5-alpha-steroid 4-dehydrogenase Proteins 0.000 abstract description 7
- 102000001779 3-oxo-5-alpha-steroid 4-dehydrogenase Human genes 0.000 abstract description 7
- 230000002401 inhibitory effect Effects 0.000 abstract description 4
- 239000000126 substance Substances 0.000 abstract description 2
- 230000000694 effects Effects 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 84
- 239000000203 mixture Substances 0.000 description 51
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 32
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 29
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 28
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 24
- 239000000243 solution Substances 0.000 description 24
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 22
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 20
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 19
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 17
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 15
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 14
- 235000019341 magnesium sulphate Nutrition 0.000 description 14
- 239000003921 oil Substances 0.000 description 14
- 239000000741 silica gel Substances 0.000 description 14
- 229910002027 silica gel Inorganic materials 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 12
- 125000000593 indol-1-yl group Chemical group [H]C1=C([H])C([H])=C2N([*])C([H])=C([H])C2=C1[H] 0.000 description 11
- 239000002904 solvent Substances 0.000 description 11
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 10
- 238000001704 evaporation Methods 0.000 description 10
- 230000008020 evaporation Effects 0.000 description 10
- 239000012044 organic layer Substances 0.000 description 9
- 125000004494 ethyl ester group Chemical group 0.000 description 8
- 229960003604 testosterone Drugs 0.000 description 8
- LACIBZRFAYFTOV-UHFFFAOYSA-N 4-[3-[3-[bis[4-(2-methylpropyl)phenyl]methylamino]benzoyl]indol-1-yl]butanoic acid Chemical compound C1=CC(CC(C)C)=CC=C1C(C=1C=CC(CC(C)C)=CC=1)NC1=CC=CC(C(=O)C=2C3=CC=CC=C3N(CCCC(O)=O)C=2)=C1 LACIBZRFAYFTOV-UHFFFAOYSA-N 0.000 description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 6
- 239000012267 brine Substances 0.000 description 6
- OBNCKNCVKJNDBV-UHFFFAOYSA-N ethyl butyrate Chemical compound CCCC(=O)OCC OBNCKNCVKJNDBV-UHFFFAOYSA-N 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 239000011541 reaction mixture Substances 0.000 description 6
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 5
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 5
- 229910000027 potassium carbonate Inorganic materials 0.000 description 5
- JNEMATJGRRPXHK-UHFFFAOYSA-N 4-[3-[3-[bis[4-(2-methylpropyl)phenyl]methylamino]benzoyl]-2-methylindol-1-yl]butanoic acid Chemical compound C1=CC(CC(C)C)=CC=C1C(C=1C=CC(CC(C)C)=CC=1)NC1=CC=CC(C(=O)C=2C3=CC=CC=C3N(CCCC(O)=O)C=2C)=C1 JNEMATJGRRPXHK-UHFFFAOYSA-N 0.000 description 3
- 201000004384 Alopecia Diseases 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- 239000012312 sodium hydride Substances 0.000 description 3
- 229910000104 sodium hydride Inorganic materials 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- RVQOLTBRWHPYTM-UHFFFAOYSA-N 1-(chloromethyl)-4-(2-methylpropyl)benzene Chemical compound CC(C)CC1=CC=C(CCl)C=C1 RVQOLTBRWHPYTM-UHFFFAOYSA-N 0.000 description 2
- JSHQATXVCGCYJQ-UHFFFAOYSA-N 4-(2-methylpropyl)aniline Chemical compound CC(C)CC1=CC=C(N)C=C1 JSHQATXVCGCYJQ-UHFFFAOYSA-N 0.000 description 2
- VLDRKOHABKMBMD-UHFFFAOYSA-N 4-[3-(3-aminobenzoyl)indol-1-yl]butanoic acid Chemical compound NC1=CC=CC(C(=O)C=2C3=CC=CC=C3N(CCCC(O)=O)C=2)=C1 VLDRKOHABKMBMD-UHFFFAOYSA-N 0.000 description 2
- DXLSUABZALDVCB-UHFFFAOYSA-N 4-[3-[3-(5,6-dihydrobenzo[b][1]benzazepin-11-ylmethyl)benzoyl]indol-1-yl]butanoic acid Chemical compound C12=CC=CC=C2CCC2=CC=CC=C2N1CC1=CC(C(=O)C2=CN(C3=CC=CC=C32)CCCC(=O)O)=CC=C1 DXLSUABZALDVCB-UHFFFAOYSA-N 0.000 description 2
- ZLHHFWKUYRDIBG-UHFFFAOYSA-N 4-[3-[3-[2,2-bis[4-(2-methylpropyl)phenyl]ethyl]benzoyl]indol-1-yl]butanoic acid Chemical compound C1=CC(CC(C)C)=CC=C1C(C=1C=CC(CC(C)C)=CC=1)CC1=CC=CC(C(=O)C=2C3=CC=CC=C3N(CCCC(O)=O)C=2)=C1 ZLHHFWKUYRDIBG-UHFFFAOYSA-N 0.000 description 2
- CWSQCOOOOMNJNI-UHFFFAOYSA-N 4-[3-[4-[bis[4-(2-methylpropyl)phenyl]methoxy]benzoyl]indol-1-yl]butanoic acid Chemical compound C1=CC(CC(C)C)=CC=C1C(C=1C=CC(CC(C)C)=CC=1)OC1=CC=C(C(=O)C=2C3=CC=CC=C3N(CCCC(O)=O)C=2)C=C1 CWSQCOOOOMNJNI-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Natural products CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- 206010020112 Hirsutism Diseases 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 206010068168 androgenetic alopecia Diseases 0.000 description 2
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 2
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 2
- XBPOBCXHALHJFP-UHFFFAOYSA-N ethyl 4-bromobutanoate Chemical compound CCOC(=O)CCCBr XBPOBCXHALHJFP-UHFFFAOYSA-N 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000003818 flash chromatography Methods 0.000 description 2
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 2
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000002985 plastic film Substances 0.000 description 2
- 210000002307 prostate Anatomy 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 238000010898 silica gel chromatography Methods 0.000 description 2
- 239000001488 sodium phosphate Substances 0.000 description 2
- 229910000162 sodium phosphate Inorganic materials 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 2
- QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 description 1
- RLLURPZAWICNPV-MDWZMJQESA-N (e)-4-[3-[3-[bis[4-(2-methylpropyl)phenyl]methylamino]benzoyl]indol-1-yl]but-2-enoic acid Chemical compound C1=CC(CC(C)C)=CC=C1C(C=1C=CC(CC(C)C)=CC=1)NC1=CC=CC(C(=O)C=2C3=CC=CC=C3N(C\C=C\C(O)=O)C=2)=C1 RLLURPZAWICNPV-MDWZMJQESA-N 0.000 description 1
- HTSGKJQDMSTCGS-UHFFFAOYSA-N 1,4-bis(4-chlorophenyl)-2-(4-methylphenyl)sulfonylbutane-1,4-dione Chemical compound C1=CC(C)=CC=C1S(=O)(=O)C(C(=O)C=1C=CC(Cl)=CC=1)CC(=O)C1=CC=C(Cl)C=C1 HTSGKJQDMSTCGS-UHFFFAOYSA-N 0.000 description 1
- WORJRXHJTUTINR-UHFFFAOYSA-N 1,4-dioxane;hydron;chloride Chemical compound Cl.C1COCCO1 WORJRXHJTUTINR-UHFFFAOYSA-N 0.000 description 1
- DXXDWAKXLYZQPB-UHFFFAOYSA-N 1-(1-bromo-2,2-dimethylpropyl)-4-(2-methylpropyl)benzene Chemical compound CC(C)CC1=CC=C(C(Br)C(C)(C)C)C=C1 DXXDWAKXLYZQPB-UHFFFAOYSA-N 0.000 description 1
- JLLGMLODKYNBKJ-UHFFFAOYSA-N 1-(1-bromopropyl)-4-(2-methylpropyl)benzene Chemical compound CCC(Br)C1=CC=C(CC(C)C)C=C1 JLLGMLODKYNBKJ-UHFFFAOYSA-N 0.000 description 1
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 1
- YSIJIZJIBMUQFC-UHFFFAOYSA-N 1-[chloro-[4-(2-methylpropyl)phenyl]methyl]-4-(2-methylpropyl)benzene Chemical compound C1=CC(CC(C)C)=CC=C1C(Cl)C1=CC=C(CC(C)C)C=C1 YSIJIZJIBMUQFC-UHFFFAOYSA-N 0.000 description 1
- NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 description 1
- HQJVYBPPQOIDJP-UHFFFAOYSA-N 2-[3-[1-(4-ethoxy-4-oxobutyl)indole-3-carbonyl]phenoxy]-2-[4-(2-methylpropyl)phenyl]acetic acid Chemical compound C12=CC=CC=C2N(CCCC(=O)OCC)C=C1C(=O)C(C=1)=CC=CC=1OC(C(O)=O)C1=CC=C(CC(C)C)C=C1 HQJVYBPPQOIDJP-UHFFFAOYSA-N 0.000 description 1
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 1
- YIBKHPCMCMZYID-UHFFFAOYSA-N 3-[3-[3-[bis[4-(2-methylpropyl)phenyl]methylamino]benzoyl]indol-1-yl]propanoic acid Chemical compound C1=CC(CC(C)C)=CC=C1C(C=1C=CC(CC(C)C)=CC=1)NC1=CC=CC(C(=O)C=2C3=CC=CC=C3N(CCC(O)=O)C=2)=C1 YIBKHPCMCMZYID-UHFFFAOYSA-N 0.000 description 1
- 229940105325 3-dimethylaminopropylamine Drugs 0.000 description 1
- GDEHXPCZWFXRKC-UHFFFAOYSA-N 4-(2-methylpropyl)phenol Chemical compound CC(C)CC1=CC=C(O)C=C1 GDEHXPCZWFXRKC-UHFFFAOYSA-N 0.000 description 1
- FFLHDCSTDJMQFW-UHFFFAOYSA-N 4-[3-(3-hydroxybenzoyl)indol-1-yl]butanoic acid Chemical compound C12=CC=CC=C2N(CCCC(=O)O)C=C1C(=O)C1=CC=CC(O)=C1 FFLHDCSTDJMQFW-UHFFFAOYSA-N 0.000 description 1
- DYFPQFXAZBSSTA-UHFFFAOYSA-N 4-[3-(4-hydroxybenzoyl)indol-1-yl]butanoic acid Chemical compound C12=CC=CC=C2N(CCCC(=O)O)C=C1C(=O)C1=CC=C(O)C=C1 DYFPQFXAZBSSTA-UHFFFAOYSA-N 0.000 description 1
- SASZOCABMGRLFV-UHFFFAOYSA-N 4-[3-[3,5-bis[(2-methylpropan-2-yl)oxycarbonyl-[[4-(2-methylpropyl)phenyl]methyl]amino]benzoyl]indol-1-yl]butanoic acid Chemical compound C1=CC(CC(C)C)=CC=C1CN(C(=O)OC(C)(C)C)C1=CC(N(CC=2C=CC(CC(C)C)=CC=2)C(=O)OC(C)(C)C)=CC(C(=O)C=2C3=CC=CC=C3N(CCCC(O)=O)C=2)=C1 SASZOCABMGRLFV-UHFFFAOYSA-N 0.000 description 1
- BOIFXAJBSHKOQX-UHFFFAOYSA-N 4-[3-[3-(azepane-1-carbonylamino)benzoyl]indol-1-yl]butanoic acid Chemical compound C12=CC=CC=C2N(CCCC(=O)O)C=C1C(=O)C(C=1)=CC=CC=1NC(=O)N1CCCCCC1 BOIFXAJBSHKOQX-UHFFFAOYSA-N 0.000 description 1
- VAQBWIDUGRDQNN-UHFFFAOYSA-N 4-[3-[3-(phenothiazin-10-ylmethyl)benzoyl]indol-1-yl]butanoic acid Chemical compound C12=CC=CC=C2N(CCCC(=O)O)C=C1C(=O)C1=CC=CC(CN2C3=CC=CC=C3SC3=CC=CC=C32)=C1 VAQBWIDUGRDQNN-UHFFFAOYSA-N 0.000 description 1
- MQYCLTIQGXHXIF-UHFFFAOYSA-N 4-[3-[3-[(2-methylpropan-2-yl)oxycarbonylamino]benzoyl]indol-1-yl]butanoic acid Chemical compound CC(C)(C)OC(=O)NC1=CC=CC(C(=O)C=2C3=CC=CC=C3N(CCCC(O)=O)C=2)=C1 MQYCLTIQGXHXIF-UHFFFAOYSA-N 0.000 description 1
- DZPOADNLRCURJW-UHFFFAOYSA-N 4-[3-[3-[1-[3-(2-methylpropyl)phenyl]ethoxy]benzoyl]indol-1-yl]butanoic acid Chemical compound CC(C)CC1=CC=CC(C(C)OC=2C=C(C=CC=2)C(=O)C=2C3=CC=CC=C3N(CCCC(O)=O)C=2)=C1 DZPOADNLRCURJW-UHFFFAOYSA-N 0.000 description 1
- YDYOHRSGQAIDPH-UHFFFAOYSA-N 4-[3-[3-[1-[4-(2-methylpropyl)phenyl]ethylamino]benzoyl]indol-1-yl]butanoic acid Chemical compound C1=CC(CC(C)C)=CC=C1C(C)NC1=CC=CC(C(=O)C=2C3=CC=CC=C3N(CCCC(O)=O)C=2)=C1 YDYOHRSGQAIDPH-UHFFFAOYSA-N 0.000 description 1
- NMRKXXAUPJHOJM-UHFFFAOYSA-N 4-[3-[3-[2-(tert-butylamino)-1-[4-(2-methylpropyl)phenyl]-2-oxoethoxy]benzoyl]indol-1-yl]butanoic acid Chemical compound C1=CC(CC(C)C)=CC=C1C(C(=O)NC(C)(C)C)OC1=CC=CC(C(=O)C=2C3=CC=CC=C3N(CCCC(O)=O)C=2)=C1 NMRKXXAUPJHOJM-UHFFFAOYSA-N 0.000 description 1
- SILHXQGNIUVAHC-UHFFFAOYSA-N 4-[3-[3-[2-[4-(2-methylpropyl)anilino]-1-[4-(2-methylpropyl)phenyl]-2-oxoethoxy]benzoyl]indol-1-yl]butanoic acid Chemical compound C1=CC(CC(C)C)=CC=C1NC(=O)C(C=1C=CC(CC(C)C)=CC=1)OC1=CC=CC(C(=O)C=2C3=CC=CC=C3N(CCCC(O)=O)C=2)=C1 SILHXQGNIUVAHC-UHFFFAOYSA-N 0.000 description 1
- YSIVUYKRVCPJTF-UHFFFAOYSA-N 4-[3-[3-[2-anilino-1-[4-(2-methylpropyl)phenyl]-2-oxoethoxy]benzoyl]indol-1-yl]butanoic acid Chemical compound C1=CC(CC(C)C)=CC=C1C(C(=O)NC=1C=CC=CC=1)OC1=CC=CC(C(=O)C=2C3=CC=CC=C3N(CCCC(O)=O)C=2)=C1 YSIVUYKRVCPJTF-UHFFFAOYSA-N 0.000 description 1
- JIAQCKTXFOWPQC-UHFFFAOYSA-N 4-[3-[3-[4-(2-methylpropyl)-n-[2-[4-(2-methylpropyl)anilino]-2-oxoethyl]anilino]benzoyl]indol-1-yl]butanoic acid Chemical compound C1=CC(CC(C)C)=CC=C1NC(=O)CN(C=1C=C(C=CC=1)C(=O)C=1C2=CC=CC=C2N(CCCC(O)=O)C=1)C1=CC=C(CC(C)C)C=C1 JIAQCKTXFOWPQC-UHFFFAOYSA-N 0.000 description 1
- ADKKPBWEIJRIJN-UHFFFAOYSA-N 4-[3-[3-[[2,2-dimethyl-1-[4-(2-methylpropyl)phenyl]propyl]-methylamino]benzoyl]indol-1-yl]butanoic acid Chemical compound C1=CC(CC(C)C)=CC=C1C(C(C)(C)C)N(C)C1=CC=CC(C(=O)C=2C3=CC=CC=C3N(CCCC(O)=O)C=2)=C1 ADKKPBWEIJRIJN-UHFFFAOYSA-N 0.000 description 1
- ODFQJTCFRJHYCC-UHFFFAOYSA-N 4-[3-[3-[[3-(2-methylpropyl)anilino]methyl]benzoyl]indol-1-yl]butanoic acid Chemical compound CC(C)CC1=CC=CC(NCC=2C=C(C=CC=2)C(=O)C=2C3=CC=CC=C3N(CCCC(O)=O)C=2)=C1 ODFQJTCFRJHYCC-UHFFFAOYSA-N 0.000 description 1
- WHBGFWQMZOKDIT-UHFFFAOYSA-N 4-[3-[3-[[3-(2-methylpropyl)phenoxy]methyl]benzoyl]indol-1-yl]butanoic acid Chemical compound CC(C)CC1=CC=CC(OCC=2C=C(C=CC=2)C(=O)C=2C3=CC=CC=C3N(CCCC(O)=O)C=2)=C1 WHBGFWQMZOKDIT-UHFFFAOYSA-N 0.000 description 1
- PNQAOEXYUWHRDR-UHFFFAOYSA-N 4-[3-[3-[[4-(2-methylpropyl)anilino]methyl]benzoyl]indol-1-yl]butanoic acid Chemical compound C1=CC(CC(C)C)=CC=C1NCC1=CC=CC(C(=O)C=2C3=CC=CC=C3N(CCCC(O)=O)C=2)=C1 PNQAOEXYUWHRDR-UHFFFAOYSA-N 0.000 description 1
- KKWDKFPOCLTDSF-UHFFFAOYSA-N 4-[3-[3-[[4-(2-methylpropyl)phenoxy]methyl]benzoyl]indol-1-yl]butanoic acid Chemical compound C1=CC(CC(C)C)=CC=C1OCC1=CC=CC(C(=O)C=2C3=CC=CC=C3N(CCCC(O)=O)C=2)=C1 KKWDKFPOCLTDSF-UHFFFAOYSA-N 0.000 description 1
- WLJUHDYDSFKUIK-UHFFFAOYSA-N 4-[3-[3-[[4-(2-methylpropyl)phenyl]methyl-phenylmethoxycarbonylamino]benzoyl]indol-1-yl]butanoic acid Chemical compound C1=CC(CC(C)C)=CC=C1CN(C=1C=C(C=CC=1)C(=O)C=1C2=CC=CC=C2N(CCCC(O)=O)C=1)C(=O)OCC1=CC=CC=C1 WLJUHDYDSFKUIK-UHFFFAOYSA-N 0.000 description 1
- ZPRIPTOHEKZNSE-UHFFFAOYSA-N 4-[3-[3-[[4-(2-methylpropyl)phenyl]methylamino]benzoyl]indol-1-yl]butanoic acid Chemical compound C1=CC(CC(C)C)=CC=C1CNC1=CC=CC(C(=O)C=2C3=CC=CC=C3N(CCCC(O)=O)C=2)=C1 ZPRIPTOHEKZNSE-UHFFFAOYSA-N 0.000 description 1
- DQASTISFUCFYFE-UHFFFAOYSA-N 4-[3-[3-[benzyl-[1-[4-(2-methylpropyl)phenyl]ethyl]amino]benzoyl]indol-1-yl]butanoic acid Chemical compound C1=CC(CC(C)C)=CC=C1C(C)N(C=1C=C(C=CC=1)C(=O)C=1C2=CC=CC=C2N(CCCC(O)=O)C=1)CC1=CC=CC=C1 DQASTISFUCFYFE-UHFFFAOYSA-N 0.000 description 1
- SOJGLXHCKAALHU-UHFFFAOYSA-N 4-[3-[3-[benzyl-[1-[4-(2-methylpropyl)phenyl]propyl]amino]benzoyl]indol-1-yl]butanoic acid Chemical compound C=1C=C(CC(C)C)C=CC=1C(CC)N(C=1C=C(C=CC=1)C(=O)C=1C2=CC=CC=C2N(CCCC(O)=O)C=1)CC1=CC=CC=C1 SOJGLXHCKAALHU-UHFFFAOYSA-N 0.000 description 1
- UBMJUXHMTOOFJB-UHFFFAOYSA-N 4-[3-[3-[benzyl-[bis[4-(2-methylpropyl)phenyl]methyl]amino]benzoyl]indol-1-yl]butanoic acid Chemical compound C1=CC(CC(C)C)=CC=C1C(C=1C=CC(CC(C)C)=CC=1)N(C=1C=C(C=CC=1)C(=O)C=1C2=CC=CC=C2N(CCCC(O)=O)C=1)CC1=CC=CC=C1 UBMJUXHMTOOFJB-UHFFFAOYSA-N 0.000 description 1
- YIXNXDFPEZBTTM-UHFFFAOYSA-N 4-[3-[3-[bis(4-chlorophenyl)methylamino]benzoyl]indol-1-yl]butanoic acid Chemical compound C12=CC=CC=C2N(CCCC(=O)O)C=C1C(=O)C(C=1)=CC=CC=1NC(C=1C=CC(Cl)=CC=1)C1=CC=C(Cl)C=C1 YIXNXDFPEZBTTM-UHFFFAOYSA-N 0.000 description 1
- NUENLZBLRIZSAE-UHFFFAOYSA-N 4-[3-[3-[bis[4-(2-methylpropyl)phenyl]methoxy]benzoyl]indol-1-yl]butanoic acid Chemical compound C1=CC(CC(C)C)=CC=C1C(C=1C=CC(CC(C)C)=CC=1)OC1=CC=CC(C(=O)C=2C3=CC=CC=C3N(CCCC(O)=O)C=2)=C1 NUENLZBLRIZSAE-UHFFFAOYSA-N 0.000 description 1
- TVXMSFKNMZWIQX-UHFFFAOYSA-N 4-[3-[3-[bis[4-(2-methylpropyl)phenyl]methyl-methylamino]benzoyl]indol-1-yl]butanoic acid Chemical compound C1=CC(CC(C)C)=CC=C1C(C=1C=CC(CC(C)C)=CC=1)N(C)C1=CC=CC(C(=O)C=2C3=CC=CC=C3N(CCCC(O)=O)C=2)=C1 TVXMSFKNMZWIQX-UHFFFAOYSA-N 0.000 description 1
- HPQYRGUFQWDXGX-UHFFFAOYSA-N 4-[3-[3-[bis[4-(2-methylpropyl)phenyl]methylamino]benzoyl]-5-chloroindol-1-yl]butanoic acid Chemical compound C1=CC(CC(C)C)=CC=C1C(C=1C=CC(CC(C)C)=CC=1)NC1=CC=CC(C(=O)C=2C3=CC(Cl)=CC=C3N(CCCC(O)=O)C=2)=C1 HPQYRGUFQWDXGX-UHFFFAOYSA-N 0.000 description 1
- PGCAMUPFSRRLEW-UHFFFAOYSA-N 4-[3-[3-[bis[[4-(2-methylpropyl)phenyl]methyl]amino]benzoyl]indol-1-yl]butanoic acid Chemical compound C1=CC(CC(C)C)=CC=C1CN(C=1C=C(C=CC=1)C(=O)C=1C2=CC=CC=C2N(CCCC(O)=O)C=1)CC1=CC=C(CC(C)C)C=C1 PGCAMUPFSRRLEW-UHFFFAOYSA-N 0.000 description 1
- AOYPHTYVXRTKGN-UHFFFAOYSA-N 4-[3-[3-[cyano-[[4-(2-methylpropyl)phenyl]methyl]amino]benzoyl]indol-1-yl]butanoic acid Chemical compound C1=CC(CC(C)C)=CC=C1CN(C#N)C1=CC=CC(C(=O)C=2C3=CC=CC=C3N(CCCC(O)=O)C=2)=C1 AOYPHTYVXRTKGN-UHFFFAOYSA-N 0.000 description 1
- BJCKHLSREBTCSK-UHFFFAOYSA-N 4-[3-[3-[n-(2-anilino-2-oxoethyl)-4-(2-methylpropyl)anilino]benzoyl]indol-1-yl]butanoic acid Chemical compound C1=CC(CC(C)C)=CC=C1N(C=1C=C(C=CC=1)C(=O)C=1C2=CC=CC=C2N(CCCC(O)=O)C=1)CC(=O)NC1=CC=CC=C1 BJCKHLSREBTCSK-UHFFFAOYSA-N 0.000 description 1
- HSJFVSQMQMNGAA-UHFFFAOYSA-N 4-[3-[3-[n-[2-(diethylamino)-2-oxoethyl]-4-(2-methylpropyl)anilino]benzoyl]indol-1-yl]butanoic acid Chemical compound C=1C=CC(C(=O)C=2C3=CC=CC=C3N(CCCC(O)=O)C=2)=CC=1N(CC(=O)N(CC)CC)C1=CC=C(CC(C)C)C=C1 HSJFVSQMQMNGAA-UHFFFAOYSA-N 0.000 description 1
- TVGYPVSHBHHQFU-UHFFFAOYSA-N 4-[3-[3-[n-[2-(tert-butylamino)-2-oxoethyl]-4-(2-methylpropyl)anilino]benzoyl]indol-1-yl]butanoic acid Chemical compound C1=CC(CC(C)C)=CC=C1N(CC(=O)NC(C)(C)C)C1=CC=CC(C(=O)C=2C3=CC=CC=C3N(CCCC(O)=O)C=2)=C1 TVGYPVSHBHHQFU-UHFFFAOYSA-N 0.000 description 1
- SMSOYFGWXDACGL-UHFFFAOYSA-N 4-[3-[4-[1-[4-(2-methylpropyl)phenyl]ethoxy]benzoyl]indol-1-yl]butanoic acid Chemical compound C1=CC(CC(C)C)=CC=C1C(C)OC1=CC=C(C(=O)C=2C3=CC=CC=C3N(CCCC(O)=O)C=2)C=C1 SMSOYFGWXDACGL-UHFFFAOYSA-N 0.000 description 1
- PHUSGIMEPRLCIO-UHFFFAOYSA-N 4-[3-[4-[1-[4-(2-methylpropyl)phenyl]ethylamino]benzoyl]indol-1-yl]butanoic acid Chemical compound C1=CC(CC(C)C)=CC=C1C(C)NC1=CC=C(C(=O)C=2C3=CC=CC=C3N(CCCC(O)=O)C=2)C=C1 PHUSGIMEPRLCIO-UHFFFAOYSA-N 0.000 description 1
- IOWHTEDCOYJQFS-UHFFFAOYSA-N 4-[3-[4-[1-[4-(2-methylpropyl)phenyl]propoxy]benzoyl]indol-1-yl]butanoic acid Chemical compound C=1C=C(C(=O)C=2C3=CC=CC=C3N(CCCC(O)=O)C=2)C=CC=1OC(CC)C1=CC=C(CC(C)C)C=C1 IOWHTEDCOYJQFS-UHFFFAOYSA-N 0.000 description 1
- VUZRGHJAFNLTQI-UHFFFAOYSA-N 4-[3-[4-[2,2-bis[4-(2-methylpropyl)phenyl]ethyl]benzoyl]indol-1-yl]butanoic acid Chemical compound C1=CC(CC(C)C)=CC=C1C(C=1C=CC(CC(C)C)=CC=1)CC1=CC=C(C(=O)C=2C3=CC=CC=C3N(CCCC(O)=O)C=2)C=C1 VUZRGHJAFNLTQI-UHFFFAOYSA-N 0.000 description 1
- CUEPRQJLWZCPBH-UHFFFAOYSA-N 4-[3-[4-[2,2-dimethyl-1-[4-(2-methylpropyl)phenyl]propoxy]benzoyl]indol-1-yl]butanoic acid Chemical compound C1=CC(CC(C)C)=CC=C1C(C(C)(C)C)OC1=CC=C(C(=O)C=2C3=CC=CC=C3N(CCCC(O)=O)C=2)C=C1 CUEPRQJLWZCPBH-UHFFFAOYSA-N 0.000 description 1
- MKJKUFQLICJCPC-UHFFFAOYSA-N 4-[3-[4-[2-(diethylamino)-1-[4-(2-methylpropyl)phenyl]-2-oxoethoxy]benzoyl]indol-1-yl]butanoic acid Chemical compound C=1C=C(C(=O)C=2C3=CC=CC=C3N(CCCC(O)=O)C=2)C=CC=1OC(C(=O)N(CC)CC)C1=CC=C(CC(C)C)C=C1 MKJKUFQLICJCPC-UHFFFAOYSA-N 0.000 description 1
- YQQCEUORTWIJRD-UHFFFAOYSA-N 4-[3-[4-[2-(tert-butylamino)-1-[4-(2-methylpropyl)phenyl]-2-oxoethoxy]benzoyl]indol-1-yl]butanoic acid Chemical compound C1=CC(CC(C)C)=CC=C1C(C(=O)NC(C)(C)C)OC1=CC=C(C(=O)C=2C3=CC=CC=C3N(CCCC(O)=O)C=2)C=C1 YQQCEUORTWIJRD-UHFFFAOYSA-N 0.000 description 1
- IOOJGFLMKWTOKB-UHFFFAOYSA-N 4-[3-[4-[2-[4-(2-methylpropyl)anilino]-1-[4-(2-methylpropyl)phenyl]-2-oxoethoxy]benzoyl]indol-1-yl]butanoic acid Chemical compound C1=CC(CC(C)C)=CC=C1NC(=O)C(C=1C=CC(CC(C)C)=CC=1)OC1=CC=C(C(=O)C=2C3=CC=CC=C3N(CCCC(O)=O)C=2)C=C1 IOOJGFLMKWTOKB-UHFFFAOYSA-N 0.000 description 1
- KLLVOATWNJTAIN-UHFFFAOYSA-N 4-[3-[4-[2-anilino-1-[4-(2-methylpropyl)phenyl]-2-oxoethoxy]benzoyl]indol-1-yl]butanoic acid Chemical compound C1=CC(CC(C)C)=CC=C1C(C(=O)NC=1C=CC=CC=1)OC1=CC=C(C(=O)C=2C3=CC=CC=C3N(CCCC(O)=O)C=2)C=C1 KLLVOATWNJTAIN-UHFFFAOYSA-N 0.000 description 1
- LDZCYSLGLVBIMB-UHFFFAOYSA-N 4-[3-[4-[bis[4-(2-methylpropyl)phenyl]methylamino]benzoyl]indol-1-yl]butanoic acid Chemical compound C1=CC(CC(C)C)=CC=C1C(C=1C=CC(CC(C)C)=CC=1)NC1=CC=C(C(=O)C=2C3=CC=CC=C3N(CCCC(O)=O)C=2)C=C1 LDZCYSLGLVBIMB-UHFFFAOYSA-N 0.000 description 1
- PKVHXPGSOSOUFM-UHFFFAOYSA-N 4-[3-[4-[carboxy-[4-(2-methylpropyl)phenyl]methoxy]benzoyl]indol-1-yl]butanoic acid Chemical compound C1=CC(CC(C)C)=CC=C1C(C(O)=O)OC1=CC=C(C(=O)C=2C3=CC=CC=C3N(CCCC(O)=O)C=2)C=C1 PKVHXPGSOSOUFM-UHFFFAOYSA-N 0.000 description 1
- KGNDPAQGGVNWMN-UHFFFAOYSA-N 4-[3-[5-[bis[4-(2-methylpropyl)phenyl]methylamino]furan-2-carbonyl]indol-1-yl]butanoic acid Chemical compound C1=CC(CC(C)C)=CC=C1C(C=1C=CC(CC(C)C)=CC=1)NC1=CC=C(C(=O)C=2C3=CC=CC=C3N(CCCC(O)=O)C=2)O1 KGNDPAQGGVNWMN-UHFFFAOYSA-N 0.000 description 1
- RTMQTNXKXJHTLA-UHFFFAOYSA-N 4-[3-[[3-[bis[4-(2-methylpropyl)phenyl]methylamino]phenyl]methyl]indol-1-yl]-4-oxobutanoic acid Chemical compound C1=CC(CC(C)C)=CC=C1C(C=1C=CC(CC(C)C)=CC=1)NC1=CC=CC(CC=2C3=CC=CC=C3N(C(=O)CCC(O)=O)C=2)=C1 RTMQTNXKXJHTLA-UHFFFAOYSA-N 0.000 description 1
- MLEBCBXUJZTQRH-UHFFFAOYSA-N 4-[3-[[3-[bis[4-(2-methylpropyl)phenyl]methylamino]phenyl]methyl]indol-1-yl]butanoic acid Chemical compound C1=CC(CC(C)C)=CC=C1C(C=1C=CC(CC(C)C)=CC=1)NC1=CC=CC(CC=2C3=CC=CC=C3N(CCCC(O)=O)C=2)=C1 MLEBCBXUJZTQRH-UHFFFAOYSA-N 0.000 description 1
- XZZVXUYOTFXMRB-UHFFFAOYSA-N 5-[3-[3-[bis[4-(2-methylpropyl)phenyl]methylamino]benzoyl]indol-1-yl]pentanoic acid Chemical compound C1=CC(CC(C)C)=CC=C1C(C=1C=CC(CC(C)C)=CC=1)NC1=CC=CC(C(=O)C=2C3=CC=CC=C3N(CCCCC(O)=O)C=2)=C1 XZZVXUYOTFXMRB-UHFFFAOYSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 description 1
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000004403 Prostatic Hyperplasia Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 206010036976 Prostatism Diseases 0.000 description 1
- 206010037888 Rash pustular Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- AQEIQZAMQVBWRA-UHFFFAOYSA-N [3-[1-(4-ethoxy-4-oxobutyl)indole-3-carbonyl]phenyl]-[[4-(2-methylpropyl)phenyl]methyl]carbamic acid Chemical compound C12=CC=CC=C2N(CCCC(=O)OCC)C=C1C(=O)C(C=1)=CC=CC=1N(C(O)=O)CC1=CC=C(CC(C)C)C=C1 AQEIQZAMQVBWRA-UHFFFAOYSA-N 0.000 description 1
- IDHSWKLUDIIFLD-UHFFFAOYSA-N [3-[2,2-bis[4-(2-methylpropyl)phenyl]ethyl]phenyl]-(1h-indol-3-yl)methanone Chemical compound C1=CC(CC(C)C)=CC=C1C(C=1C=CC(CC(C)C)=CC=1)CC1=CC=CC(C(=O)C=2C3=CC=CC=C3NC=2)=C1 IDHSWKLUDIIFLD-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 201000002996 androgenic alopecia Diseases 0.000 description 1
- LVTRSDPGFGCSIU-UHFFFAOYSA-N benzyl 4-[3-[3-(benzylamino)benzoyl]indol-1-yl]butanoate Chemical compound C=1C=CC=CC=1COC(=O)CCCN(C1=CC=CC=C11)C=C1C(=O)C(C=1)=CC=CC=1NCC1=CC=CC=C1 LVTRSDPGFGCSIU-UHFFFAOYSA-N 0.000 description 1
- VTURGYUNMNSUNW-UHFFFAOYSA-N benzyl 4-[3-[3-[benzyl-[1-[4-(2-methylpropyl)phenyl]ethyl]amino]benzoyl]indol-1-yl]butanoate Chemical compound C1=CC(CC(C)C)=CC=C1C(C)N(C=1C=C(C=CC=1)C(=O)C=1C2=CC=CC=C2N(CCCC(=O)OCC=2C=CC=CC=2)C=1)CC1=CC=CC=C1 VTURGYUNMNSUNW-UHFFFAOYSA-N 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
- SIOVKLKJSOKLIF-UHFFFAOYSA-N bis(trimethylsilyl)acetamide Chemical compound C[Si](C)(C)OC(C)=N[Si](C)(C)C SIOVKLKJSOKLIF-UHFFFAOYSA-N 0.000 description 1
- PIJXRNNCIJAUOX-UHFFFAOYSA-N butanoic acid;hydrochloride Chemical compound Cl.CCCC(O)=O PIJXRNNCIJAUOX-UHFFFAOYSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001085 differential centrifugation Methods 0.000 description 1
- IUNMPGNGSSIWFP-UHFFFAOYSA-N dimethylaminopropylamine Chemical compound CN(C)CCCN IUNMPGNGSSIWFP-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- FXFTVPBXTMNCHX-UHFFFAOYSA-N ethyl 3-[3-[3-[bis[4-(2-methylpropyl)phenyl]methylamino]benzoyl]indol-1-yl]propanoate Chemical compound C12=CC=CC=C2N(CCC(=O)OCC)C=C1C(=O)C(C=1)=CC=CC=1NC(C=1C=CC(CC(C)C)=CC=1)C1=CC=C(CC(C)C)C=C1 FXFTVPBXTMNCHX-UHFFFAOYSA-N 0.000 description 1
- LOMAGEXOLYEGOQ-UHFFFAOYSA-N ethyl 4-[3-(3-hydroxybenzoyl)indol-1-yl]butanoate Chemical compound C12=CC=CC=C2N(CCCC(=O)OCC)C=C1C(=O)C1=CC=CC(O)=C1 LOMAGEXOLYEGOQ-UHFFFAOYSA-N 0.000 description 1
- YCOILJNYQOEWNG-UHFFFAOYSA-N ethyl 4-[3-[2,3-dimethyl-4-[1-[4-(2-methylpropyl)phenyl]ethoxy]benzoyl]indol-1-yl]butanoate Chemical compound C12=CC=CC=C2N(CCCC(=O)OCC)C=C1C(=O)C(C(=C1C)C)=CC=C1OC(C)C1=CC=C(CC(C)C)C=C1 YCOILJNYQOEWNG-UHFFFAOYSA-N 0.000 description 1
- FHAGDJUXFCLTEY-UHFFFAOYSA-N ethyl 4-[3-[3,5-bis[(2-methylpropan-2-yl)oxycarbonylamino]benzoyl]indol-1-yl]butanoate Chemical compound C12=CC=CC=C2N(CCCC(=O)OCC)C=C1C(=O)C1=CC(NC(=O)OC(C)(C)C)=CC(NC(=O)OC(C)(C)C)=C1 FHAGDJUXFCLTEY-UHFFFAOYSA-N 0.000 description 1
- IEHRTWGASZMIJT-UHFFFAOYSA-N ethyl 4-[3-[3-(phenothiazin-10-ylmethyl)benzoyl]indol-1-yl]butanoate Chemical compound C12=CC=CC=C2N(CCCC(=O)OCC)C=C1C(=O)C1=CC=CC(CN2C3=CC=CC=C3SC3=CC=CC=C32)=C1 IEHRTWGASZMIJT-UHFFFAOYSA-N 0.000 description 1
- TXDJEXVRJHEPRQ-UHFFFAOYSA-N ethyl 4-[3-[3-[1-[3-(2-methylpropyl)phenyl]ethoxy]benzoyl]indol-1-yl]butanoate Chemical compound C12=CC=CC=C2N(CCCC(=O)OCC)C=C1C(=O)C(C=1)=CC=CC=1OC(C)C1=CC=CC(CC(C)C)=C1 TXDJEXVRJHEPRQ-UHFFFAOYSA-N 0.000 description 1
- SZXXDWXQQDGOIT-UHFFFAOYSA-N ethyl 4-[3-[3-[2-(tert-butylamino)-1-[4-(2-methylpropyl)phenyl]-2-oxoethoxy]benzoyl]indol-1-yl]butanoate Chemical compound C12=CC=CC=C2N(CCCC(=O)OCC)C=C1C(=O)C(C=1)=CC=CC=1OC(C(=O)NC(C)(C)C)C1=CC=C(CC(C)C)C=C1 SZXXDWXQQDGOIT-UHFFFAOYSA-N 0.000 description 1
- ZPCJMWXQDRYJAM-UHFFFAOYSA-N ethyl 4-[3-[3-[2-[4-(2-methylpropyl)anilino]-1-[4-(2-methylpropyl)phenyl]-2-oxoethoxy]benzoyl]indol-1-yl]butanoate Chemical compound C12=CC=CC=C2N(CCCC(=O)OCC)C=C1C(=O)C(C=1)=CC=CC=1OC(C=1C=CC(CC(C)C)=CC=1)C(=O)NC1=CC=C(CC(C)C)C=C1 ZPCJMWXQDRYJAM-UHFFFAOYSA-N 0.000 description 1
- IEGUKIZJPSWZMV-UHFFFAOYSA-N ethyl 4-[3-[3-[2-anilino-1-[4-(2-methylpropyl)phenyl]-2-oxoethoxy]benzoyl]indol-1-yl]butanoate Chemical compound C12=CC=CC=C2N(CCCC(=O)OCC)C=C1C(=O)C(C=1)=CC=CC=1OC(C=1C=CC(CC(C)C)=CC=1)C(=O)NC1=CC=CC=C1 IEGUKIZJPSWZMV-UHFFFAOYSA-N 0.000 description 1
- OAOIYSHRCHUROO-UHFFFAOYSA-N ethyl 4-[3-[3-[4-(2-methylpropyl)-n-[2-[4-(2-methylpropyl)anilino]-2-oxoethyl]anilino]benzoyl]indol-1-yl]butanoate Chemical compound C12=CC=CC=C2N(CCCC(=O)OCC)C=C1C(=O)C(C=1)=CC=CC=1N(C=1C=CC(CC(C)C)=CC=1)CC(=O)NC1=CC=C(CC(C)C)C=C1 OAOIYSHRCHUROO-UHFFFAOYSA-N 0.000 description 1
- BWTHGZAGVPPJQX-UHFFFAOYSA-N ethyl 4-[3-[3-[[2,2-dimethyl-1-[4-(2-methylpropyl)phenyl]propyl]-methylamino]benzoyl]indol-1-yl]butanoate Chemical class C12=CC=CC=C2N(CCCC(=O)OCC)C=C1C(=O)C(C=1)=CC=CC=1N(C)C(C(C)(C)C)C1=CC=C(CC(C)C)C=C1 BWTHGZAGVPPJQX-UHFFFAOYSA-N 0.000 description 1
- LXVVEMQBXPPGSD-UHFFFAOYSA-N ethyl 4-[3-[3-[[3-(2-methylpropyl)anilino]methyl]benzoyl]indol-1-yl]butanoate Chemical compound C12=CC=CC=C2N(CCCC(=O)OCC)C=C1C(=O)C(C=1)=CC=CC=1CNC1=CC=CC(CC(C)C)=C1 LXVVEMQBXPPGSD-UHFFFAOYSA-N 0.000 description 1
- VJDINWSWPGHASO-UHFFFAOYSA-N ethyl 4-[3-[3-[[4-(2-methylpropyl)phenoxy]methyl]benzoyl]indol-1-yl]butanoate Chemical compound C12=CC=CC=C2N(CCCC(=O)OCC)C=C1C(=O)C(C=1)=CC=CC=1COC1=CC=C(CC(C)C)C=C1 VJDINWSWPGHASO-UHFFFAOYSA-N 0.000 description 1
- QIFRBOSACOLSDT-UHFFFAOYSA-N ethyl 4-[3-[3-[[4-(2-methylpropyl)phenyl]methyl-phenylmethoxycarbonylamino]benzoyl]indol-1-yl]butanoate Chemical compound C12=CC=CC=C2N(CCCC(=O)OCC)C=C1C(=O)C(C=1)=CC=CC=1N(C(=O)OCC=1C=CC=CC=1)CC1=CC=C(CC(C)C)C=C1 QIFRBOSACOLSDT-UHFFFAOYSA-N 0.000 description 1
- PGZFSLVXJQUJOV-UHFFFAOYSA-N ethyl 4-[3-[3-[bis(4-chlorophenyl)methylamino]benzoyl]indol-1-yl]butanoate Chemical compound C12=CC=CC=C2N(CCCC(=O)OCC)C=C1C(=O)C(C=1)=CC=CC=1NC(C=1C=CC(Cl)=CC=1)C1=CC=C(Cl)C=C1 PGZFSLVXJQUJOV-UHFFFAOYSA-N 0.000 description 1
- OAGMKDDUZUKYSE-UHFFFAOYSA-N ethyl 4-[3-[3-[bis[4-(2-methylpropyl)phenyl]methyl-methylamino]benzoyl]indol-1-yl]butanoate Chemical compound C12=CC=CC=C2N(CCCC(=O)OCC)C=C1C(=O)C(C=1)=CC=CC=1N(C)C(C=1C=CC(CC(C)C)=CC=1)C1=CC=C(CC(C)C)C=C1 OAGMKDDUZUKYSE-UHFFFAOYSA-N 0.000 description 1
- FHVGDHBQECIXLL-UHFFFAOYSA-N ethyl 4-[3-[3-[bis[4-(2-methylpropyl)phenyl]methylamino]benzoyl]indol-1-yl]but-2-enoate Chemical compound C12=CC=CC=C2N(CC=CC(=O)OCC)C=C1C(=O)C(C=1)=CC=CC=1NC(C=1C=CC(CC(C)C)=CC=1)C1=CC=C(CC(C)C)C=C1 FHVGDHBQECIXLL-UHFFFAOYSA-N 0.000 description 1
- XOYIVKLEUPFOFZ-UHFFFAOYSA-N ethyl 4-[3-[3-[bis[4-(2-methylpropyl)phenyl]methylamino]benzoyl]indol-1-yl]butanoate Chemical compound C12=CC=CC=C2N(CCCC(=O)OCC)C=C1C(=O)C(C=1)=CC=CC=1NC(C=1C=CC(CC(C)C)=CC=1)C1=CC=C(CC(C)C)C=C1 XOYIVKLEUPFOFZ-UHFFFAOYSA-N 0.000 description 1
- LRQIDUARGKASOU-UHFFFAOYSA-N ethyl 4-[3-[3-[cyano-[[4-(2-methylpropyl)phenyl]methyl]amino]benzoyl]indol-1-yl]butanoate Chemical compound C12=CC=CC=C2N(CCCC(=O)OCC)C=C1C(=O)C(C=1)=CC=CC=1N(C#N)CC1=CC=C(CC(C)C)C=C1 LRQIDUARGKASOU-UHFFFAOYSA-N 0.000 description 1
- XGHCFLZSJMSYTO-UHFFFAOYSA-N ethyl 4-[3-[3-[n-[2-(diethylamino)-2-oxoethyl]-4-(2-methylpropyl)anilino]benzoyl]indol-1-yl]butanoate Chemical compound C12=CC=CC=C2N(CCCC(=O)OCC)C=C1C(=O)C(C=1)=CC=CC=1N(CC(=O)N(CC)CC)C1=CC=C(CC(C)C)C=C1 XGHCFLZSJMSYTO-UHFFFAOYSA-N 0.000 description 1
- DCUJBUWIIPKQKG-UHFFFAOYSA-N ethyl 4-[3-[3-[n-[2-(tert-butylamino)-2-oxoethyl]-4-(2-methylpropyl)anilino]benzoyl]indol-1-yl]butanoate Chemical compound C12=CC=CC=C2N(CCCC(=O)OCC)C=C1C(=O)C(C=1)=CC=CC=1N(CC(=O)NC(C)(C)C)C1=CC=C(CC(C)C)C=C1 DCUJBUWIIPKQKG-UHFFFAOYSA-N 0.000 description 1
- JWYIHUBXXCTPSK-UHFFFAOYSA-N ethyl 4-[3-[4-[1-[4-(2-methylpropyl)phenyl]-2-oxo-2-phenylmethoxyethoxy]benzoyl]indol-1-yl]butanoate Chemical compound C12=CC=CC=C2N(CCCC(=O)OCC)C=C1C(=O)C(C=C1)=CC=C1OC(C=1C=CC(CC(C)C)=CC=1)C(=O)OCC1=CC=CC=C1 JWYIHUBXXCTPSK-UHFFFAOYSA-N 0.000 description 1
- RVGLEPKPQZOWOO-UHFFFAOYSA-N ethyl 4-[3-[4-[1-[4-(2-methylpropyl)phenyl]propoxy]benzoyl]indol-1-yl]butanoate Chemical compound C12=CC=CC=C2N(CCCC(=O)OCC)C=C1C(=O)C(C=C1)=CC=C1OC(CC)C1=CC=C(CC(C)C)C=C1 RVGLEPKPQZOWOO-UHFFFAOYSA-N 0.000 description 1
- WPXJJJJIUUMIGE-UHFFFAOYSA-N ethyl 4-[3-[4-[2,2-bis[4-(2-methylpropyl)phenyl]ethyl]benzoyl]indol-1-yl]butanoate Chemical compound C12=CC=CC=C2N(CCCC(=O)OCC)C=C1C(=O)C(C=C1)=CC=C1CC(C=1C=CC(CC(C)C)=CC=1)C1=CC=C(CC(C)C)C=C1 WPXJJJJIUUMIGE-UHFFFAOYSA-N 0.000 description 1
- CXDAFJOXBXXHPW-UHFFFAOYSA-N ethyl 4-[3-[4-[2-(tert-butylamino)-1-[4-(2-methylpropyl)phenyl]-2-oxoethoxy]benzoyl]indol-1-yl]butanoate Chemical compound C12=CC=CC=C2N(CCCC(=O)OCC)C=C1C(=O)C(C=C1)=CC=C1OC(C(=O)NC(C)(C)C)C1=CC=C(CC(C)C)C=C1 CXDAFJOXBXXHPW-UHFFFAOYSA-N 0.000 description 1
- KVMUCZQMZGYZKD-UHFFFAOYSA-N ethyl 4-[3-[5-[bis[4-(2-methylpropyl)phenyl]methylamino]furan-2-carbonyl]indol-1-yl]butanoate Chemical compound C12=CC=CC=C2N(CCCC(=O)OCC)C=C1C(=O)C(O1)=CC=C1NC(C=1C=CC(CC(C)C)=CC=1)C1=CC=C(CC(C)C)C=C1 KVMUCZQMZGYZKD-UHFFFAOYSA-N 0.000 description 1
- KXRKONAKJIFDSA-UHFFFAOYSA-N ethyl 4-[3-[[3-[bis[4-(2-methylpropyl)phenyl]methylamino]phenyl]methyl]indol-1-yl]butanoate Chemical compound C12=CC=CC=C2N(CCCC(=O)OCC)C=C1CC(C=1)=CC=CC=1NC(C=1C=CC(CC(C)C)=CC=1)C1=CC=C(CC(C)C)C=C1 KXRKONAKJIFDSA-UHFFFAOYSA-N 0.000 description 1
- CMNLBVOUWCWZPT-UHFFFAOYSA-N ethyl 5-[3-[3-[bis[4-(2-methylpropyl)phenyl]methylamino]benzoyl]indol-1-yl]pentanoate Chemical compound C12=CC=CC=C2N(CCCCC(=O)OCC)C=C1C(=O)C(C=1)=CC=CC=1NC(C=1C=CC(CC(C)C)=CC=1)C1=CC=C(CC(C)C)C=C1 CMNLBVOUWCWZPT-UHFFFAOYSA-N 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 201000010066 hyperandrogenism Diseases 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910003480 inorganic solid Inorganic materials 0.000 description 1
- 235000015122 lemonade Nutrition 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 1
- DXHFGXROUPUGAG-UHFFFAOYSA-N methyl 4-[3-[3-[methyl-[1-[4-(2-methylpropyl)phenyl]propyl]amino]benzoyl]indol-1-yl]butanoate Chemical compound C=1C=CC(C(=O)C=2C3=CC=CC=C3N(CCCC(=O)OC)C=2)=CC=1N(C)C(CC)C1=CC=C(CC(C)C)C=C1 DXHFGXROUPUGAG-UHFFFAOYSA-N 0.000 description 1
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 229950006238 nadide Drugs 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- AICOOMRHRUFYCM-ZRRPKQBOSA-N oxazine, 1 Chemical compound C([C@@H]1[C@H](C(C[C@]2(C)[C@@H]([C@H](C)N(C)C)[C@H](O)C[C@]21C)=O)CC1=CC2)C[C@H]1[C@@]1(C)[C@H]2N=C(C(C)C)OC1 AICOOMRHRUFYCM-ZRRPKQBOSA-N 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 201000004240 prostatic hypertrophy Diseases 0.000 description 1
- 201000007094 prostatitis Diseases 0.000 description 1
- 208000029561 pustule Diseases 0.000 description 1
- 239000005297 pyrex Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- DVUBTLDALRQHCY-UHFFFAOYSA-M sodium 4-[3-[3-[bis[4-(2-methylpropyl)phenyl]methylamino]benzoyl]indol-1-yl]butanoate Chemical compound CC(C)CC1=CC=C(C=C1)C(C2=CC=C(C=C2)CC(C)C)NC3=CC=CC(=C3)C(=O)C4=CN(C5=CC=CC=C54)CCCC(=O)[O-].[Na+] DVUBTLDALRQHCY-UHFFFAOYSA-M 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an alkyl or cycloalkyl radical attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9011335.8 | 1990-05-21 | ||
| GB909011335A GB9011335D0 (en) | 1990-05-21 | 1990-05-21 | Indolebutyric acid derivatives and process for preparation thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2045518C1 true RU2045518C1 (ru) | 1995-10-10 |
Family
ID=10676312
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU914895529A RU2045518C1 (ru) | 1990-05-21 | 1991-05-20 | Производные индола или их фармацевтически приемлемые соли и способ их получения |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0458207B1 (enExample) |
| JP (1) | JPH0678307B2 (enExample) |
| KR (1) | KR910019975A (enExample) |
| CN (1) | CN1030701C (enExample) |
| AT (1) | ATE150747T1 (enExample) |
| AU (1) | AU645560B2 (enExample) |
| CA (1) | CA2042905A1 (enExample) |
| DE (1) | DE69125308T2 (enExample) |
| DK (1) | DK0458207T3 (enExample) |
| FI (1) | FI912375A7 (enExample) |
| GB (1) | GB9011335D0 (enExample) |
| GR (1) | GR3022953T3 (enExample) |
| HU (2) | HUT60471A (enExample) |
| IE (1) | IE911641A1 (enExample) |
| NO (1) | NO175475C (enExample) |
| PT (1) | PT97717B (enExample) |
| RU (1) | RU2045518C1 (enExample) |
| ZA (1) | ZA913457B (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2120942C1 (ru) * | 1991-06-17 | 1998-10-27 | Фудзисава Фармасьютикал Ко., Лтд. | ПРОИЗВОДНЫЕ ИНДОЛИЗИНА, СПОСОБ ИХ ПОЛУЧЕНИЯ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, СПОСОБ ИНГИБИРОВАНИЯ ТЕСТОСТЕРОН 5α-РЕДУКТАЗЫ |
| US5334716A (en) * | 1991-06-17 | 1994-08-02 | Fujisawa Pharmaceutical Co., Ltd. | Heterocyclic derivatives |
| GB9115951D0 (en) * | 1991-07-24 | 1991-09-11 | Pfizer Ltd | Indoles |
| CA2118697A1 (en) * | 1991-09-11 | 1993-03-18 | Satoshi Okada | Indole derivatives as 5-alpha-reductase inhibitor |
| GB9127531D0 (en) * | 1991-12-31 | 1992-02-19 | Fujisawa Pharmaceutical Co | Heterocyclic compound |
| GB9204024D0 (en) * | 1992-02-25 | 1992-04-08 | Fujisawa Pharmaceutical Co | Indole derivatives |
| GB9204365D0 (en) * | 1992-02-28 | 1992-04-08 | Pfizer Ltd | Indoles |
| KR950701527A (ko) * | 1992-05-21 | 1995-04-28 | 라브리 페르낭 | 테스토스테론 5α 환원효소 활성 저해제(INHIBITORS OF TESTOSTERONE 5α-REDUCTASE ACTIVITY) |
| GB9302577D0 (en) * | 1993-02-10 | 1993-03-24 | Fujisawa Pharmaceutical Co | Indole derivatives |
| US5530019A (en) * | 1993-04-05 | 1996-06-25 | Fujisawa Pharmaceutical Co., Ltd. | Indole derivatives useful as testosterone 5α-reductase inhibitors |
| GB9310092D0 (en) * | 1993-05-17 | 1993-06-30 | Fujisawa Pharmaceutical Co | Indole derivatives |
| IL109728A0 (en) * | 1993-05-28 | 1994-08-26 | Pfizer Res & Dev | Indoles |
| GB9317096D0 (en) * | 1993-08-17 | 1993-09-29 | Pfizer Ltd | Indoles |
| US5760040A (en) * | 1994-03-30 | 1998-06-02 | Zeria Pharmaceutical Co., Ltd. | Indole derivative for treating overproduction of dihydrotestosterone |
| GB9409583D0 (en) * | 1994-05-13 | 1994-07-06 | Pfizer Ltd | Indoles |
| AP2000001929A0 (en) * | 1998-03-31 | 2000-09-30 | Inst For Pharm Discovery Inc | Substituted indolealkanoic acids. |
| WO2003020311A1 (fr) * | 2001-08-28 | 2003-03-13 | Fujisawa Pharmaceutical Co., Ltd. | Remedes contre les maladies de la peau |
| ATE406363T1 (de) | 2003-05-09 | 2008-09-15 | Hoffmann La Roche | Methylindole und methylpyrrolopyridine als alpha- 1-adrenerge agonisten |
| TW201329025A (zh) * | 2011-11-01 | 2013-07-16 | Astex Therapeutics Ltd | 醫藥化合物 |
| EP3774767B1 (en) * | 2018-04-05 | 2025-10-29 | Beth Israel Deaconess Medical Center, Inc. | Aryl hydrocarbon receptor modulators and uses thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR7337M (enExample) * | 1968-01-11 | 1969-10-13 | ||
| PH23498A (en) * | 1984-08-06 | 1989-08-16 | Sterling Drug Inc | 3-carbonyl-1-aminoalkyl-1h-indoles,composition and use thereof |
-
1990
- 1990-05-21 GB GB909011335A patent/GB9011335D0/en active Pending
-
1991
- 1991-05-07 ZA ZA913457A patent/ZA913457B/xx unknown
- 1991-05-13 IE IE164191A patent/IE911641A1/en unknown
- 1991-05-16 FI FI912375A patent/FI912375A7/fi not_active Application Discontinuation
- 1991-05-16 AU AU77116/91A patent/AU645560B2/en not_active Ceased
- 1991-05-16 NO NO911938A patent/NO175475C/no unknown
- 1991-05-17 DE DE69125308T patent/DE69125308T2/de not_active Expired - Fee Related
- 1991-05-17 CA CA002042905A patent/CA2042905A1/en not_active Abandoned
- 1991-05-17 EP EP91108019A patent/EP0458207B1/en not_active Expired - Lifetime
- 1991-05-17 AT AT91108019T patent/ATE150747T1/de not_active IP Right Cessation
- 1991-05-17 DK DK91108019.0T patent/DK0458207T3/da active
- 1991-05-20 KR KR1019910008139A patent/KR910019975A/ko not_active Ceased
- 1991-05-20 CN CN91103461A patent/CN1030701C/zh not_active Expired - Fee Related
- 1991-05-20 PT PT97717A patent/PT97717B/pt not_active IP Right Cessation
- 1991-05-20 HU HU911681A patent/HUT60471A/hu unknown
- 1991-05-20 RU SU914895529A patent/RU2045518C1/ru active
- 1991-05-21 JP JP3229864A patent/JPH0678307B2/ja not_active Expired - Fee Related
-
1995
- 1995-06-22 HU HU95P/P00391P patent/HU211637A9/hu unknown
-
1997
- 1997-03-27 GR GR970400551T patent/GR3022953T3/el unknown
Non-Patent Citations (1)
| Title |
|---|
| Вейганд-Хильгетаг, Методы эксперимента в органической химии, Изд.: Химия, 1968, с.427. * |
Also Published As
| Publication number | Publication date |
|---|---|
| NO911938L (no) | 1991-11-22 |
| DE69125308T2 (de) | 1997-07-10 |
| NO175475B (no) | 1994-07-11 |
| HU211637A9 (en) | 1995-12-28 |
| CA2042905A1 (en) | 1991-11-22 |
| JPH04244061A (ja) | 1992-09-01 |
| PT97717B (pt) | 1998-08-31 |
| CN1030701C (zh) | 1996-01-17 |
| DK0458207T3 (enExample) | 1997-04-21 |
| NO911938D0 (no) | 1991-05-16 |
| AU7711691A (en) | 1991-11-21 |
| DE69125308D1 (de) | 1997-04-30 |
| PT97717A (pt) | 1992-02-28 |
| GR3022953T3 (en) | 1997-06-30 |
| EP0458207A2 (en) | 1991-11-27 |
| AU645560B2 (en) | 1994-01-20 |
| FI912375A7 (fi) | 1991-11-22 |
| CN1056685A (zh) | 1991-12-04 |
| IE911641A1 (en) | 1991-12-04 |
| ATE150747T1 (de) | 1997-04-15 |
| KR910019975A (ko) | 1991-12-19 |
| EP0458207B1 (en) | 1997-03-26 |
| HU911681D0 (en) | 1991-11-28 |
| NO175475C (no) | 1994-10-19 |
| JPH0678307B2 (ja) | 1994-10-05 |
| HUT60471A (en) | 1992-09-28 |
| GB9011335D0 (en) | 1990-07-11 |
| FI912375A0 (fi) | 1991-05-16 |
| ZA913457B (en) | 1992-02-26 |
| EP0458207A3 (en) | 1992-03-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sugiura et al. | Syntheses and antiinflammatory and hypnotic activity of 5-alkoxy-3-(N-substituted carbamoyl)-1-phenylpyrazoles. 4 | |
| AU652016B2 (en) | Treatment for tissue ulceration | |
| US4515803A (en) | Substituted derivatives of octahydroindole-2-carboxylic acids | |
| US5276021A (en) | Phosphorus-containing HMG-COA reductase inhibitors, new intermediates and method | |
| CA1169428A (en) | Indole derivatives | |
| US3810906A (en) | N1-heteroacylated phenylhydrazines | |
| AU2782599A (en) | Inhibitors of phospholipase enzymes | |
| AU645560B2 (en) | Indole derivatives | |
| US5455262A (en) | Mercaptosulfide metalloproteinase inhibitors | |
| EP0516849B1 (en) | Indole derivatives | |
| FR2659656A1 (fr) | Derives de pyrimidinedione-2,4 et medicaments les contenant. | |
| CA1299174C (en) | Alkylmelatonins | |
| CN108218800B (zh) | 1，2，3-三氮唑类氨肽酶n抑制剂及其制备方法和应用 | |
| ES2322260T3 (es) | Nuevos derivados de acetona sustituidos con heteroarilo en calidad de inhibidores de la fosfolipasa a2. | |
| US4401676A (en) | Novel α-amino acids | |
| US5312829A (en) | Indole derivatives | |
| JPH07597B2 (ja) | 抗炎症性３‐アシル‐２‐オキシインドール‐１‐カルボキシドアミド類の前駆物質 | |
| CA1236834A (en) | Substituted 1-pyridyloxy-3-indolylalkylamino-2- propanols, preparation, and use thereof | |
| JPH02275846A (ja) | カルボン酸誘導体 | |
| CA2118697A1 (en) | Indole derivatives as 5-alpha-reductase inhibitor | |
| WO2007107383A1 (de) | Indolderivate als inhibitoren der löslichen adenylatzyklase | |
| US3535334A (en) | 1-piperonoyl-3-indolyl aliphatic acid derivatives | |
| US5212320A (en) | Indole derivatives and their use for testosterone 5-alpha-reductase-mediated diseases | |
| EP4003969A1 (fr) | Inhibiteurs selectifs du transporteur bcrp/abcg2 utilises comme agents pour abolir la resistance aux anticancereux | |
| US5283251A (en) | Indole derivatives |